| Literature DB >> 34460209 |
Rafał Krzysztoń1, Yiming Wan1, Julia Petreczky1, Gábor Balázsi1.
Abstract
Therapeutic genome modification requires precise control over the introduced therapeutic functions. Current approaches of gene and cell therapy fail to deliver such command and rely on semi-quantitative methods with limited influence on timing, contextuality and levels of transgene expression, and hence on therapeutic function. Synthetic biology offers new opportunities for quantitative functionality in designing therapeutic systems and their components. Here, we discuss synthetic biology tools in their therapeutic context, with examples of proof-of-principle and clinical applications of engineered synthetic biomolecules and higher-order functional systems, i.e. gene circuits. We also present the prospects of future development towards advanced gene-circuit therapy.Entities:
Mesh:
Year: 2021 PMID: 34460209 PMCID: PMC8590856 DOI: 10.18388/abp.2020_5744
Source DB: PubMed Journal: Acta Biochim Pol ISSN: 0001-527X Impact factor: 2.149